ENTRY       D05389                      Drug
NAME        Pegnartograstim (USAN/INN)
SEQUENCE    MAPTYRASSL PQSFLLKSLE QVRKIQGDGA ALQEKLCATY KLCHPEELVL LGHSLGIPWA
            PLSSCPSQAL QLAGCLSQLH SGLFLYQGLL QALEGISPEL GPTLDTLQLD VADFATTIWQ
            QMEELGMAPA LQPTQGAMPA FASAFQRRAG GVLVASHLQS FLEVSYRVLR HLAQP
            (Disulfide bridge: 37-43, 65-75)
  TYPE      Peptide
CLASS       Immunological agent
             DG01753  Colony stimulating factor
              DG01781  Granulocyte colony stimulating factor (G-CSF)
EFFICACY    Antineoplastic, Immunomodulator
COMMENT     see Nartograstim [DR:D03245]
            Parenteral adjuvant to anticancer chemotherapy
TARGET      CSF3R (GCSFR, CD114) [HSA:1441] [KO:K05061]
  PATHWAY   hsa04060(1441)  Cytokine-cytokine receptor interaction
            hsa04630(1441)  JAK-STAT signaling pathway
BRITE       Drug groups [BR:br08330]
             Immunological agent
              DG01753  Colony stimulating factor
               DG01781  Granulocyte colony stimulating factor (G-CSF)
                D05389  Pegnartograstim
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               CSF and other factor receptors
                CSF3R (GCSFR, CD114)
                 D05389  Pegnartograstim (USAN/INN)
DBLINKS     CAS: 204565-76-4
            PubChem: 47207065
///
